Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Temc CNS Co. Ltd. (241790:KRX), powered by AI.
Temc CNS Co. Ltd. is currently trading at ₩8,200. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Temc CNS Co. Ltd. on Alpha Lenz.
Temc CNS Co. Ltd.'s P/E ratio is 8.4.
“Temc CNS Co. Ltd. trades at a P/E of 8.4 (undervalued) with solid ROE of 8.8%. 3Y revenue CAGR of 27.2% highlights clear growth momentum.”
Ask for details →Temc CNS Co. Ltd. is a prominent player in the technology sector, primarily focusing on the design and development of semiconductor solutions. These solutions find applications across various high-demand industries such as consumer electronics, automotive, and industrial automation, thereby facilitating enhanced performance and innovation. The company's portfolio includes the production of advanced integrated circuits and microchips which are critical in powering everyday gadgets, sophisticated vehicle systems, and industrial machinery. Known for its robust research and development initiatives, Temc CNS Co. Ltd. aligns its operations with the ever-evolving technological landscape to cater to the increasing demand for efficient and scalable semiconductor products. The role of Temc CNS in the financial market is underscored by its contribution to the tech industry, as semiconductors are a foundational element in modern electronics, impacting global supply chains and technological advancements. By continuously pushing the envelope in semiconductor technology, Temc CNS Co. Ltd. helps drive both innovation and competition within the tech market.
“Temc CNS Co. Ltd. trades at a P/E of 8.4 (undervalued) with solid ROE of 8.8%. 3Y revenue CAGR of 27.2% highlights clear growth momentum.”
Ask for details →Temc CNS Co. Ltd. (ticker: 241790) is a company listed on KRX in the Technology sector (Semiconductor Equipment & Materials). It has approximately 165 employees. Market cap is $82.0B.
The current price is ₩8,200 with a P/E ratio of 8.41x and P/B of 0.72x.
ROE is 8.84% and operating margin is 3.06%. Annual revenue is $193.5B.